The Japanese Pharmaceutical Industry: Its Evolution and Current Challenges

ISBN-13: 9780415587662 / Angielski / Twarda / 2011 / 190 str.

Maki Umemura;¬Abar;¬Abar

Opis

This text explores why Japan, despite being the world leader in many high technology industries, is only a minor player in the global pharmaceutical industry. Focusing on antibiotics and anticancer drugs, the book analyses factors that have prevented Japan from leading the rapid advances in science and technology.

Recenzje

'The Japanese Pharmaceutical Industry is an ambitious, broad-ranging analysis of the postwar history of an industry whose eight per cent share of Japanese manufacturing understates its significance in terms of health and as a barometer for science-based innovation.' - Robert Kneller, University of Tokyo; Journal of Japanese Studies, 2013.

Spis treści

1. Introduction: Why didn’t Japan become a global leader in pharmaceuticals?  2. A historical overview of Japan’s pharmaceutical industry  3. Developing a modern industry: The antibiotics sector  4. What went wrong? The anticancer drug sector  5. Conclusion: Reconsidering Japan’s business in pharmaceuticals 

O autorze

Maki Umemura is a lecturer in Japanese studies at Cardiff Business School, Cardiff University, UK.